DEA announces new policy “designed to increase the number of entities registered under the Controlled Substances Act (CSA) to grow (manufacture) marijuana to supply legitimate researchers in the United States” August 11, 2016
DEA concludes that there is “no substantial evidence that marijuana should be removed from schedule I” August 11, 2016
Bipartisan Medical Marijuana Research Act of 2016 gets support from most vocal opponents and supporters of reform June 20, 2016
